A股異動 | 生益科技(600183.SH)跌逾5% 股東偉華電子擬減持不超1%公司股份
格隆匯8月18日丨生益科技(600183.SH)低開低走,現報24.87元,跌5.69%,暫成交4億元,最新市值572億元。生益科技昨日晚間公佈,截至公吿披露日,公司股東偉華電子持有公司股份326,283,920股,佔公司總股本的14.17%,為公司第三大股東。偉華電子擬自減持計劃公吿之日起15個交易日後的3個月內(即減持期間是2021年9月8日至2021年12月7日),採用集中競價方式按市場價格減持不超過2302.4743萬股,不超過公司總股本的1%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.